These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32600242)

  • 1. Selenium: A Trace Element for a Healthy Skeleton - A Narrative Review.
    Vescini F; Chiodini I; Palermo A; Cesareo R; De Geronimo V; Scillitani A; Gennari L; Falchetti A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):577-585. PubMed ID: 32600242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium in bone health: roles in antioxidant protection and cell proliferation.
    Zeng H; Cao JJ; Combs GF
    Nutrients; 2013 Jan; 5(1):97-110. PubMed ID: 23306191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women.
    Ahn SH; Lee SH; Kim BJ; Lim KH; Bae SJ; Kim EH; Kim HK; Choe JW; Koh JM; Kim GS
    Osteoporos Int; 2013 Dec; 24(12):2961-70. PubMed ID: 23644878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of calcium on bone mass in postmenopausal women with high selenium intake.
    Pedrera-Zamorano JD; Calderon-García JF; Roncero-Martin R; Mañas-Nuñez P; Moran JM; Lavado-Garcia JM
    J Nutr Health Aging; 2012; 16(9):743-8. PubMed ID: 23131814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postmenopausal bone loss and treatment of osteoporosis.
    Kleerekoper M
    Semin Reprod Med; 2005 May; 23(2):141-8. PubMed ID: 15852199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
    Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dietary selenium intake and the prevalence of osteoporosis: a cross-sectional study.
    Wang Y; Xie D; Li J; Long H; Wu J; Wu Z; He H; Wang H; Yang T; Wang Y
    BMC Musculoskelet Disord; 2019 Dec; 20(1):585. PubMed ID: 31801509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status.
    Rosen CJ; Tenenhouse A
    Postgrad Med; 1998 Oct; 104(4):101-2, 107-10, 113-4. PubMed ID: 9793558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol: A Simple Nutrient with Complex Actions on Bone in the Adult Skeleton.
    Gaddini GW; Turner RT; Grant KA; Iwaniec UT
    Alcohol Clin Exp Res; 2016 Apr; 40(4):657-71. PubMed ID: 26971854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone remodeling].
    Lerner UH; Ljunggren O
    Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women.
    Hoeg A; Gogakos A; Murphy E; Mueller S; Köhrle J; Reid DM; Glüer CC; Felsenberg D; Roux C; Eastell R; Schomburg L; Williams GR
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4061-70. PubMed ID: 22904175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy.
    Vestergaard P
    Curr Drug Saf; 2008 Sep; 3(3):168-72. PubMed ID: 18690996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
    Seeman E
    Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
    Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of risedronate on fracture risk in postmenopausal women with osteopenia.
    Siris ES; Simon JA; Barton IP; McClung MR; Grauer A
    Osteoporos Int; 2008 May; 19(5):681-6. PubMed ID: 17968610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V; Fontas E; Chapurlat R; Panaia-Ferrari P; Yahia HB; Faure S; Euller-Ziegler L; Amri EZ; Szulc P
    Osteoporos Int; 2015 Dec; 26(12):2877-82. PubMed ID: 26109496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
    Anagnostis P; Vyzantiadis TA; Charizopoulou M; Adamidou F; Karras S; Goulis DG; Karagiannis A; Garipidou V; Vakalopoulou S
    Thromb Haemost; 2013 Aug; 110(2):257-63. PubMed ID: 23740140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.